FTRE Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $36.47 = $364.7
FTRE Prices
View the FTRE historical prices.
52WL $24.93
The 52 Week Low is $24.93 set on Mon, Aug 21, 2023.
52WH $41.02
The 52 Week High is $41.02 set on Fri, Mar 1, 2024. The current price, $36.47, is 0% below the 52 Week High.
ATH $38.27
The All-Time High is $38.27 set on Fri, Mar 1, 2024. The current price, $36.47, is 0% below the All Time High.
52 Week Range
FTRE Dividends
FTRE has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
FTRE Profile
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
